2024 Asia Conference on Lung Cancer (ACLC) - Poster & ePosters-ACLC23 ePoster List

ACLC23 ePoster List
Pdf Summary
The ACLC24 ePoster list includes a diverse range of studies focused primarily on lung cancer research, exploring both basic scientific understanding and clinical treatment strategies. Below is a summary of the topics covered:<br /><br />1. **Frailty, Sarcopenia, and Nutritional Status**: Investigates their correlation in lung cancer patients undergoing chemotherapy, highlighting the importance of evaluating physical and nutritional health (Yan Wang).<br /><br />2. **Radiation Pneumonitis Risk**: A meta-analysis examining risks for NSCLC patients exposed to specific radiation levels in SBRT, contributing to better radiation planning (Gloriamaris Loy-Caraos).<br /><br />3. **Neoadjuvant Therapy in Small Cell Lung Cancer**: Retrospective study revealing pathological responses, providing insights for treatment refinements (Liwei Song).<br /><br />4. **Neutrophil Extracellular Traps and Metastasis**: A study linking ITGB1 CAFs and IL-8 in metastasis, emphasizing molecular pathways for potential therapeutic targets (Yuquan Bai).<br /><br />5. **Differential Diagnosis of Immune-Related Pneumonia**: Utilizing CT-based radiomics, this research advances non-invasive diagnostic techniques (Tingyue Luo).<br /><br />6. **Lungpro Navigational Bronchoscopy**: Evaluates its utility in diagnosing peripheral lung cancer, suggesting improvements in diagnostic accuracy (Feng Ying).<br /><br />7. **PD-L1 Expression and Targeted Therapy Efficacy**: Investigates the relationship in NSCLC patients, aiding personalized medicine approaches (Quan-quan Tan).<br /><br />8. **EGFR-TKIs Rechallenge with Bevacizumab**: Assesses efficacy in treating EGFR-mutant NSCLC post initial treatment progression (Bingfei Xu).<br /><br />9. **Response to Crizotinib/Breveltinib**: Analyzes patient resistance patterns providing critical data for treatment adjustments (Jiao Yang).<br /><br />10. **Nomograms and Prognostication**: Several studies develop nomograms based on radiomics and clinicopathologic factors to predict outcomes in lung cancer, enhancing personalized treatment strategies (Ying Li, Yintao Li).<br /><br />11. **Impact of COVID-19 on Surgery Outcomes**: A multicenter study assesses surgical outcomes in patients with a COVID-19 history, contributing to risk management (Hanbo Pan).<br /><br />This poster list reflects significant advancements in lung cancer treatment and management, promising improved patient outcomes and personalization of therapies.
Keywords
lung cancer
chemotherapy
radiation pneumonitis
neoadjuvant therapy
metastasis
immune-related pneumonia
bronchoscopy
PD-L1 expression
EGFR-TKIs
COVID-19